AtaiBeckley (ATAI) Cash from Financing Activities (2020 - 2026)

AtaiBeckley (ATAI) recorded quarterly Cash from Financing Activities of $821000.0 in Q1 2026, down 98.62% quarter-over-quarter from $59.6 million in Q1 2025, and down 98.62% on a YoY basis from $59.6 million in Q1 2025.

AtaiBeckley (ATAI) Cash from Financing Activities (2020 - 2026) Analysis & Trends

AtaiBeckley has disclosed Cash from Financing Activities across 6 years of filings, most recently posting $59.7 million for Q3 2025.

  • Cash from Financing Activities for Q3 2025 came in at $59.7 million, up 1120.76% year-over-year; the trailing twelve-month figure through Sep 2025 was $127.3 million (up 4026.57% YoY), and the FY2024 annual result was $5.4 million, up 164.32% from the prior year.
  • Cash from Financing Activities was $821000.0 for Q1 2026 at AtaiBeckley, down from $59.6 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $59.6 million in Q1 2025 to a low of $821000.0 in Q1 2026.
  • The 5-year median for Cash from Financing Activities is $1.8 million (2022), against an average of $32.6 million.
  • Across the five-year window, Cash from Financing Activities plunged 817.68% in 2023 and surged 2279.45% in 2025, its largest moves.
  • AtaiBeckley's Cash from Financing Activities stood at $1.7 million in 2021, then plunged by 153.51% to -$922000.0 in 2022, then slumped by 817.68% to -$8.5 million in 2023, then jumped by 101.82% to $154000.0 in 2024, then soared by 38694.81% to $59.7 million in 2025.
  • The last three Cash from Financing Activities figures came in at $59.7 million (Q3 2025), $7.8 million (Q2 2025), and $59.6 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 AtaiBeckley 1.45 Bn 1.45 Bn - 821,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 821,000.00
Mar 31, 2026 821,000.00
Sep 30, 2025 59.74 Mn
Sep 30, 2025 59.74 Mn
Jun 30, 2025 7.76 Mn
Jun 30, 2025 7.76 Mn
Mar 31, 2025 59.61 Mn
Mar 31, 2025 59.61 Mn
Mar 31, 2025 59.61 Mn
Mar 31, 2025 59.61 Mn
Dec 31, 2024 154,000.00
Dec 31, 2024 154,000.00
Sep 30, 2024 4.89 Mn
Sep 30, 2024 4.89 Mn
Jun 30, 2024 326,000.00
Jun 30, 2024 326,000.00
Dec 31, 2023 -8.46 Mn
Dec 31, 2023 -8.46 Mn
Jun 30, 2023 -100,000.00
Jun 30, 2023 -100,000.00